blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1915354

EP1915354 - BENZOTHIAZOLONE DERIVATIVES AS ADRENOCEPTOR AGONISTS [Right-click to bookmark this link]
Former [2008/18]NOVEL BENZOTHIAZOLONE DERIVATIVES
[2012/34]
StatusThe application is deemed to be withdrawn
Status updated on  05.07.2013
Database last updated on 21.01.2025
Most recent event   Tooltip05.07.2013Application deemed to be withdrawnpublished on 07.08.2013  [2013/32]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2008/18]
Inventor(s)01 / BONNERT, Roger
AstraZeneca R & D Charnwood Bakewell Road
Loughborough Leicestershire LE11 5RH / GB
02 / FLAHERTY, Alice
21 Endsleigh
Carrigaline, Cork / IE
03 / PAIRAUDEAU, Garry
AstraZeneca R & D Charnwood Bakewell Road
Loughborough Leicestershire LE11 5RH / GB
04 / STOCKS, Michael
AstraZeneca R & D Charnwood Bakewell Road
Loughborough Leicestershire LE11 5RH / GB
 [2008/18]
Application number, filing date06769596.503.08.2006
[2008/18]
WO2006SE00927
Priority number, dateSE2005000179309.08.2005         Original published format: SE 0501793
SE2005000191430.08.2005         Original published format: SE 0501914
SE2006000051508.03.2006         Original published format: SE 0600515
[2008/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007018461
Date:15.02.2007
Language:EN
[2007/07]
Type: A1 Application with search report 
No.:EP1915354
Date:30.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 15.02.2007 takes the place of the publication of the European patent application.
[2008/18]
Search report(s)International search report - published on:SE15.02.2007
(Supplementary) European search report - dispatched on:EP10.06.2010
ClassificationIPC:C07D277/68, A61K31/428, A61K31/4439, A61K31/454, A61P11/06, A61P11/08, C07D417/12
[2008/18]
CPC:
C07D277/68 (EP,KR,US); A61K31/428 (KR); A61P11/00 (EP);
A61P11/02 (EP); A61P11/06 (EP); A61P11/08 (EP);
A61P43/00 (EP); C07D417/12 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/18]
TitleGerman:BENZOTHIAZOLONDERIVATE ALS ADRENOZEPTORAGONISTEN[2012/34]
English:BENZOTHIAZOLONE DERIVATIVES AS ADRENOCEPTOR AGONISTS[2012/34]
French:DÉRIVÉS DE BENZOTHIAZOLONE EN TANT QU'AGONISTES DE L'ADRENOCEPTEUR[2012/34]
Former [2008/18]NEUE BENZOTHIAZOLONDERIVATE
Former [2008/18]NOVEL BENZOTHIAZOLONE DERIVATIVES
Former [2008/18]DÉRIVÉS INNOVANTS DE BENZOTHIAZOLONE
Entry into regional phase10.03.2008National basic fee paid 
10.03.2008Search fee paid 
10.03.2008Designation fee(s) paid 
10.03.2008Examination fee paid 
Examination procedure10.03.2008Examination requested  [2008/18]
30.07.2010Despatch of a communication from the examining division (Time limit: M06)
08.02.2011Reply to a communication from the examining division
12.12.2011Despatch of a communication from the examining division (Time limit: M06)
21.06.2012Reply to a communication from the examining division
25.09.2012Communication of intention to grant the patent
05.02.2013Application deemed to be withdrawn, date of legal effect  [2013/32]
14.03.2013Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2013/32]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  30.07.2010
Fees paidRenewal fee
28.03.2008Renewal fee patent year 03
31.08.2009Renewal fee patent year 04
31.08.2010Renewal fee patent year 05
31.08.2011Renewal fee patent year 06
31.08.2012Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[A]WO9323385  (FISONS PLC [GB]);
 [X]WO9710227  (ASTRA PHARMA PROD [GB], et al);
 [A]US5648370  (BONNERT ROGER VICTOR [GB], et al);
 [X]  - AUSTIN P.R. ET AL., "QSAR and the Rational Design of Long-Acting Dual D2-Receptor/Beta2-Adrenoceptor Agonists", J. MED. CHEM., (2003), vol. 46, pages 3210 - 3220, XP003003211

DOI:   http://dx.doi.org/10.1021/jm020886c
by applicantWO9208708
 WO9323385
 WO9710227
 WO9722596
 US5648370
 WO9730035
 WO9732856
 WO9813354
 WO9902166
 WO0040529
 WO0041669
 WO0192224
 WO0204434
 WO0208213
    - KIPS; PAUWELS, AM. J. RESPIR. CRIT. CARE MED., (2001), vol. 164, pages 923 - 932
    - BARNES, NATURE REVIEWS, (2004), vol. 3, pages 831 - 844
    - KOUMIS; SAMUEL, CLIN. THER., (2005), vol. 27, no. 4, pages 377 - 92
    - J MED CHEM, (2003), vol. 46, pages 3210 - 3220
    - ORGANIC PROCESS RESEARCH & DEVELOPMENT, (2004), vol. 8, no. 4, pages 628 - 642
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.